ArticleTherapeutic advances in medical oncology2023

Different associations between organ-specific immune-related adverse event and survival in non-small cell lung cancer patients treated with programmed death-1 inhibitors-based combination therapy.

Yuzhong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.